Neonatal influence of monosodium glutamate on the somatometric parameters of rats

General Physiology and Biophysics

Volumn 28, Issue SPECIAL ISSUES, 2009, Pages 155-161

  Ćirić, Milan ^a   Najman, Stevo ^b   Bojanić, Vladmila ^a   Cekić, Sneźana ^a   Neśić, Milkica ^a   Puškaš, Nela ^a  

^a Faculty of Medicine   (Serbia)

^b UNIVERSITY OF NI   (Serbia)

Author keywords

Bones; Monosodium glutamate; Obesity; Rat; Somatometry

Indexed keywords

GLUTAMATE SODIUM;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTHROPOMETRIC PARAMETERS; ARTICLE; BODY HEIGHT; BODY MASS; BONE MASS; CHILD GROWTH; CONTROLLED STUDY; FEMALE; FEMUR; MALE; NEWBORN; NONHUMAN; RAT; SEX DIFFERENCE; TAIL; TESTIS SIZE; TIBIA;

ANIMALS; ANIMALS, NEWBORN; BODY WEIGHT; FEMALE; FEMUR; MALE; ORGAN SIZE; RATS; RATS, WISTAR; SODIUM GLUTAMATE; TAIL; TESTIS; TIBIA; TIME FACTORS;

NASO; RATTUS; RATTUS NORVEGICUS;

EID: 77649258804     PISSN: 02315882     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Adamo N. J., Ratner A. (1970): Monosodium glutamate: lack of effects on brain and reproductive function in rats. Science 169, 673-674
2. Bojanić V. (1998): Study of pathogenesis of obesity induced with monosodium glutamate. (PhD thesis), University of Niš, Serbia
3. Camihort G., Gómez D. C., Luna G., Ferese C., Jurado S., Moreno G., Spinedi E., Cónsole G. (2005): Relationship between pituitary and adipose tissue after hypothalamic denervation in the female rat. A morphometric immunohistochemical study. Cells Tissues Organs 179, 192-201
4. Chaldakov G. N., Fiore M., Stankulov I. S., Manni L., Hristova M. G., Antonelli A., Ghenev P. I., Aloe L. (2004): Neurotrophin presence in human coronary atherosclerosis and metabolic syndrome: a role for NGF and BDNF in cardiovascular disease? Prog. Brain Res. 146, 279-289
5. Chandran M., Phillips S. A., Ciaraldi T., Henry R. R. (2003): Adiponectin: More than just another fat cell hormone? Diabetes Care 26, 2442-2450
6. Cock T. A., Auwerx J. (2003): Leptin: cutting the fat off the bone. Lancet 362, 1572-1574
7. Cornish J., Callon K. E., Bava U., Lin C., Naot D., Hill B. L., Grey A. B., Broom N., Myers D. E., Nicholson G. C., Reid I. R. (2002): Leptin directly regulates bone cell function in vitro and reduces bone fragility in vivo. J. Endocrinol. 175, 405-415
8. Cornish J., Callon K. E., Mountjoy K. G., Bava U., Lin J. M., Myers D. E., Naot D., Reid I. R. (2003): Alpha-melanocytestimulating hormone is a novel regulator of bone. Am. J. Physiol., Endocrinol. Metab. 284, E1181-1190
9. Ducy P., Amling M., Takeda S. (2000): Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass. Cell 100, 197-207
10. Epsinosa L., Itzstein C., Cheynel H., Delmas P., Chenu C. (1999): Active NMDA glutamate receptors are expressed by mammalian osteoclasts. J. Physiol. 518, 47-53
11. França L. R., Suescun M. O., Miranda J. R., Giovambattista A., Perello M., Spinedi E., Calandra R. S. (2006): Testis structure and function in a nongenetic hyperadipose rat model at prepubertal and adult ages. Endocrinology 147, 1556-1563
12. Guidobono F., Pagani F., Sibilia V., Netti C., Lattuada N., Rapetti D., Mrak E., Villa I., Cavani F., Bertoni L., Palumbo C., Ferretti M., Marotti G., Rubinacci A. (2006): Different skeletal regional response to continuous brain infusion of leptin in the rat. Peptides 27, 1426-1433
13. Gu Y., Genever P. G., Skerry T. M., Publicover S. J. (2002): The NMDA type glutamate receptors expressed in primary rat osteoblasts have the same electrophysiological characteristics as neuronal receptors. Calcif. Tissue Int. 70, 194-203
14. Hamerman D. (2002): Molecular-based therapeutic approaches in treatment of anorexia of aging and cancer cachexia. J. Gerontol. Med. Sci. 57, M511-518
15. Klingberg H., Brankački J., Klingberg F. (1987): Long-term effects on behaviour after postnatal treatment with monosodium-L-glutamate. Biomed. Biochem. Acta 46, 705-711
16. Kovács M., Halmos G., Groot K., Izdebski J., Schally A. V. (1996): Chronic administration of a new potent agonist of growth hormone-releasing hormone induces compensatory linear growth in growth hormone-deficient rats: mechanism of action. Neuroendocrinology 64, 169-176
17. Laketic-Ljubojevic I., Suva L. J, Maathuis F. J, Sanders D., Skerry T. M. (1999): Functional characterization of N-methyl-D-aspartic acid-gated channels in bone cells. Bone 25, 631-637
18. Millard W. J., Martin J. B. Jr., Audet J., Sagar S. M., Martin J. B. (1982): Evidence that reduced growth hormone secretion observed in monosodium glutamate-treated rats is the result of a deficiency in growth hormone-releasing factor. Endocrinology 110, 540-550
19. Miskowiak B., Limanowski A., Partyka M. (1993): Effect of perinatal administration of monosodium glutamate (MSG) on the reproductive system of the male rat. Endokrynol. Pol. 44, 497-505
20. Morroni M., De Matteis R., Palumbo C., Ferretti M., Villa I., Rubinacci A., Cinti S., Marotti G. (2004): In vivo leptin expression in cartilage and bone cells of growing rats and adult humans. J. Anat. 205, 291-296
21. Nemeroff C. B., Konkol R. J., Bissette G., Youngblood W., Martin J. B., Brazeau P., Rone M. S., Prange A. J. Jr., Breese G. R., Kizer J. S. (1977): Analysis of the disruption in hypothalamic-pituitary regulation in rats treated neonatally with monosodium glutamate (MSG): Evidence for the involvement of tuberoinfundibular cholinergic and dopaminergic systems in neuroendocrine regulation. Endocrinology 101, 613-622
22. Nikoletseas M. M. (1977): Obesity in exercising, hypophagic rats treated with monosodium glutamate. Physiol. Behav. 19, 767-773
23. Olney J. W. (1969): Brain lesions, obesity and other disturbances in mice treated with monosodium glutamate. Science 164, 719-721
24. Peet N. M., Grabowski P. S., Laketic-Ljubojevic I., Skerry T. M. (1999): The glutamate receptor antagonist MK801 modulates bone resorption by a mechanism predominantly involving osteoclast differentiation. FASEB J. 13, 2179-2185
25. Pizzi W. J., Barnhart J. E., Fanslow D. J. (1977): Monosodium glutamate administration to the newborn reduces reproductive ability in female and male mice. Science 196, 452-454
26. Redding T. W., Schally A. V., Arimura A., Wakabayashi I. (1971): Effect of monosodium glutamate on some endocrine functions. Neuroendocrinology 8, 245-255
27. Ren J. (2004): Leptin and hyperleptinemia - from friend to foe for cardiovascular function. J. Endocrinol. 181, 1-10
28. Rol de Lama M. A., Perez-Romero A., Ariznavarreta M. C., Hermanussen M., Tresguerres J. A. (1998a): Periodic growth in rats. Ann. Hum. Biol. 25, 441-541
29. Rol de Lama M. A., Pérez-Romero A., Hermanussen M., Ariznavarreta C., Tresguerres J. A. (1998b): Sexual dimorphism in growth as measured by microknemometry: different responses to GH deficiency and exogenous GH administration. Neuroendocrinology 68, 210-219
30. Shapiro B. H., MacLeod J. N., Pampori N. A., Morrissey J. J. (1989): Signaling elements in the ultradian rhythm of circulating growth hormone regulating expression of sex-dependent forms of hepatic cytochrome P450. Endocrinology 125, 2935-2944
31. Skerry T. M., Genever P. G. (2001): Glutamate signalling in nonneuronal tissues. Trends Pharmacol. Sci. 22, 174-181
32. Stevenson A. E., Evans B. A., Gevers E. F., Elford C., McLeod R. W., Perry M. J., El-Kasti M. M., Coschigano K. T., Kopchick J. J., Evans S. L., Wells T. (2009): Does adiposity status influence femoral cortical strength in rodent models of growth hormone deficiency? Am. J. Physiol., Endocrinol. Metab. 296, E147-156
33. Terry L. S., Epelbaum J., Martin J. B. (1981): Monosodium glutamate: acute and chronic effects on rhytmic growth hormone and prolactin secretion and somatostatin in the undisturbed male rat. Brain Res. 217, 129-142
34. Tamasi J. A., Arey B. J., Bertolini D. R., Feyen J. H. (2003): Characterization of bone structure in leptin receptor-deficient Zucker (fa/fa) rats. J. Bone Miner. Res. 18, 1605-1611
35. Waxman D. J., Morrissey J. J., MacLeod J. N., Shapiro B. H. (1990): Depletion of serum growth hormone in adult female rats by neonatal monosodium glutamate treatment without loss of female-specific hepatic enzymes P450 2d (IIC12) and steroid 5 alpha-reductase. Endocrinology 126, 712-720